Top 5 Takeaways from Bruce Linton’s Exclusive Interview with CFN Media at the NYC CWCB Expo


Ryan Allway

June 20th, 2019

App, Policy


CFN Media caught up with Bruce Linton, Co-CEO of Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) to discuss some of the cannabis industry’s biggest trends at the CWCB Expo in NYC in May 2019.

Sign up for the CFN Newsletter using the form in the right sidebar of this page or learn more about Becoming a Feature Company.

‘We have another decade of wild revolution.’

The cannabis industry may be maturing in places like Canada and Uruguay where it has been federally legalized, but many other countries are just starting to regulate cannabis. Linton believes that there could be another decade of uneven regulations as countries liberalize their laws — particularly in areas where cannabis has been strictly governed.

Linton cites Malaysia and Thailand as two examples of these uneven and evolving regulations. In 2018, Malaysia began to discuss legalizing cannabis after a 29-year old man was sentenced to death for possession. Thailand passed legislation to legalize medical cannabis in December 2018, but the government is struggling with how to implement the law.

‘This could get a little bit protectionist.’

Many countries that legalize cannabis decide to import since it’s the easiest path forward. That is, there’s no need to license cultivation and extraction facilities. Some countries then decide to use only a regional supply with nearby countries to support the local economy and achieve political goals. A handful have then decided to bring supply in-house.

While it’s challenging to create a domestic framework, there are a growing number of successful examples. The benefit of growing cannabis in-country is that it’s harder for people to dislike it when it supports the local economy by creating jobs.  The country could also become an exporter to nearby countries that are in the earlier stages of legalization.

‘Consumers don’t want to buy CBD, they want to buy the outcomes that CBD delivers.’

Canopy Growth’s business model has evolved to the point where they don’t want to be the grower. They want to work with other people that are in the business of tractors and property to supply the raw material. The company’s focus is on extracting cannabis concentrates to control the quality and creating the finished goods that ultimately reach consumers.

Linton sees Canopy Growth as leading the cannabis science revolution. That is, the company is focused on creating consistent products and doing the science to show that they can achieve outcomes. Stabilized ingredients power real science which creates real products. The trials involving these products are maturing and reaching the point of real insight.

‘[Europe’s cannabis industry is] not going to start the way that it did in Canada and the U.S.’

Europe has become a significant growth market over the coming years with a population that eclipses North America. Canopy Growth has expanded into Europe through a variety of acquisitions, including C3 in Germany and This Works in the UK, and sees potential in developing both pharmaceutical and consumer-focused products.

The U.S. and Canada have spent years developing and evolving their legalization frameworks. European markets will heed the lessons learned from these markets and the rollout could be very different than it was in these early markets.

‘There are so many names, I don’t even know 10% of them anymore.’

There are more than 400 publicly-traded cannabis companies and new companies are going public every week. Many of these companies are classified as “penny stocks” that trade for less than $1.00 on over-the-counter exchanges. Inexperienced investors can easily fall victim to investing in companies that invest more in PR than actually building a business.

Linton believes that cannabis ETFs are a good option for small investors — at least for a portion of their portfolios. Wealthy and/or experienced investors may look to buy a handful of cannabis companies that are larger and more reputably to capitalize on the industry’s growth.

Sign up for the CFN Newsletter using the form in the right sidebar of this page or learn more about Becoming a Feature Company.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.

Learn How Your Company can Be Covered on CFN Media

Learn More About the CFN Media Sponsored Content Program

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © TDM Financial LLC · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading